Loading company…
Riskpilot
← Back to search
Sign in
Get full access
SØR PHARMA INVEST AS
AS
Active
Org 924554037
Riseveien 9, 4848 Arendal
Retail sale of pharmaceutical products · NACE 4773
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
-30% vs 2023
Equity ratio
99.9%
Financial strength
Net profit 2024
NOK 480K
-53% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2020
0M
0%
2021
1M
+100%
2022
0M
-100%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -30K
-30%
Net profit
NOK 480K
-53%
Total assets
NOK 2,5M
+1%
Equity
NOK 2,5M
+24%
Employees
0
—
Company information
Legal name
SØR PHARMA INVEST AS
Org number
924554037
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
6. februar 2020
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eie aksjer samt investering og forvaltning av aksjer.
Contact
Address
Riseveien 9, 4848 Arendal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Arendal
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
1 000
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−2
−6
993
−23
−30
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−2
−6
993
−23
−30
Net financials
0
0
0
1 053
510
Profit before tax
−2
−6
993
1 030
480
Tax
−0
−0
2
2
−0
Net profit
−2
−6
991
1 028
480
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
176
171
1 463
2 491
2 518
Equity
23
17
1 008
2 036
2 516
Long-term debt
0
153
453
0
0
Short-term debt
153
1
2
455
2
Total debt
153
154
455
455
2
Financial ratios
5-year trend
EBITDA margin
-2972500.0%
This company
15.8%
Market median
-18813391% vs market
2020
2024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
2020
2024
Return on equity
19.1%
This company
18.4%
Market median
+4% vs market
2020
2024
Net profit margin
48028100.0%
This company
8.1%
Market median
+592939406% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-24 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
MK
Mohamad Karouni
Chairman
2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
SØR PHARMA INVEST AS
(this company)
NEDENES APOTEK AS
APOTEK 1 SALTRØD AS
Board network connections
Board members of SØR PHARMA INVEST AS also hold positions in
0
other companies.
Person
Role here
Other companies
Mohamad Karouni
Chairman
0 companies